• Mobius.bet has teamed up with top Esports company Epulze to launch the Mobius.bet Maestros – Dota 2 Tournament
• This South American tournament features a $10,000 Prize pool
• The Mobius.bet Maestros – Dota 2 Tournament runs from July 26th to August 5th

Mobius Interactive Ltd., an online Esports gaming operator, announces the Dota 2 Mobius.bet Maestros tournament in South America. This tournament features a $10,000 prize pool. To deliver this ground breaking Esports event, Mobius Interactive’s flagship site, Mobius.bet has teamed up with top Esports provider Epulze. Epulze provides a world class online platform that launches promising amateur players into the exciting and rapidly expanding world of professional Esports. Epulze also produces a wide variety of professional tournaments while hosting their own livestream productions. Having served hundreds of thousands of players in over 60,000 online tournaments—Epulze provides all levels of gamers with a safe and exciting venue for their sport. The main event will take place from July 26 through August 5th.The Mobius.bet Maestros has 8 participating teams, 7 being direct invites, while the remaining slot will be picked up by the top team from the open qualifier. The main event will consist of a Bo2 Round Robin group stage with 1 group. The top 4 teams will then advance to a double elimination playoff. Ultra Play, Mobius Interactive’s award-winning Esports platform provider, is hosting the online “Beat the Pro” event throughout the tournament. Participating Teams: SG Esports, Team UNH (Team Unknown), Infinity, Noping Esports, Binomistas, INF.UEsports, Hokori, and the qualifier winner. Lynn Pearce, Co-Founder and CEO of Mobius Interactive, sees great potential in this emerging market: “The moment Team Mobius has been waiting for has finally arrived! We have gone live with our first Esports online tournament into Brazil, Peru and the rest of the Latin American market. We are so proud to be doing this with the amazing Epulze team, their professionalism is truly astounding and we are very grateful that they chose to run this exciting Esports online tournament in Brazil with Mobius.bet. We look forward to a long-term partnership with Epulze and to the success of our first tournament in the region, running until 5th August 2021.” The event is being broadcast in English, Spanish and Portuguese on Epulze’s own and partnered channels: English: Epulze, Spanish: 4D Esports, and Portuguese: Aldeia TV. Pontus Lövgren, Epulze Co-Founder and Director of the event, is “very excited to be working with Mobius.bet.” “This partnership will give us a good opportunity. Mobius.bet Maestros will be the first in a long series of tournaments in the region and we’re happy to have Mobius.bet onboard.” Mobius Interactive Ltd. provides a variety of unique offerings catering to diverse demographic groups, powered by the award winning UltraPlay Esports platform. Their flagship brand, Mobius.bet, combines loyalty and targeted gamification into one seamless package. As a top sponsor of the 2021 FIFA World Cup Qualifiers in Brazil, the Mobius.bet brand will be seen by up to 40 million people per game on Globo TV. The team at Mobius Interactive Ltd. collectively bring over 40 years of hands-on experience to the industry. Team Mobius has created a unique iGaming experience: one that caters to the client through gamification, loyalty rewards, and exceptional customer service throughout the player journey. Mobius Interactive is open for investment opportunities. For further information please contact: Gary Eldridge – President 1 (604) 783-1685  gary@mobiusinteractive.ltdSeamus Byrne – VP Corporate Development 1 (902) 441-5757  seamus.byrne@halifaxcitrus.caTracey Miller – VP Mergers & Acquisitions 1 (604) 355-5589  tracey@mobiusinteractive.ltd For more information, visit the company’s website at www.MobiusInteractive.Ltd.

NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• Accure Acne’s groundbreaking Accure Laser System is the first commercially developed energy-based device that selectively targets and neutralizes overactive sebaceous glands
• The innovative technology is expected to position Accure as a disruptor on the vast global market of acne treatments
• By targeting only overactive glands, the system offers enhanced efficacy and a durable response; safety and efficacy have been confirmed by four IBR-approved clinical trials
• An early adopter program is already underway in the European Union, with the first orders received and delivered in Italy in Q2 2021; a broader commercial launch in several European countries is currently slated for H2 2021
• The company restarted a pivotal acne study in January 2021, with initial results expected in early 2022; this study will be essential for FDA approval in view of beginning U.S. commercialization in 2022
• Accure Acne boasts highly experienced management and scientific teams, leveraging decades of expertise in the aesthetics and medical device markets
• The company was co-founded by one of the most influential scientists in the field of energy-based devices and the co-developer of microscopic target-selective laser therapy

Accure Acne is a privately-owned medical device company focused on developing an innovative and highly efficient solution to reducing and/or preventing the recurrence of acne vulgaris. The company’s patented and patent-pending laser technology was designed to help improve acne sufferers’ long-term quality of life by offering a differentiated and impactful solution. Leveraging the extensive experience of its management and scientific teams, paired with a clear go-to-market strategy and commercialization and regulatory expertise, Accure remains committed to developing a uniquely compelling value proposition. Accure Acne is headquartered in Boulder, Colorado. The company’s flagship product, the Accure Laser System, was granted CE Mark approval for the treatment of moderate inflammatory acne in 2020, which allows the company to commercialize its product in the European Union while working to develop an exclusive global IP portfolio. Accure Laser System The company’s pioneering technology has the potential to disrupt the vast global market of acne therapeutics. It is estimated that there are 40-50 million people affected by acne vulgaris in the United States each year, while roughly 85 percent of the global population will suffer from acne at some point, according to the company’s April 2021 investor presentation. In 2016, the acne vulgaris market was estimated at $2.6 billion in the U.S. alone. Accure Acne is leveraging several competitive advantages to position itself as a leading company in the acne treatment market. Compared to the main competitors and other acne treatments in the market, the Accure Laser System is designed for efficacy and durable results, in a cost-effective treatment package. This groundbreaking system is the first commercially developed energy-based device that selectively targets and neutralizes overactive sebaceous glands present in the skin, which are the main source of sebum production and acne vulgaris. By targeting only overactive glands without damaging the surrounding epidermis, the Acne Laser System is likely to yield a durable response, starting with a significant reduction of inflammatory acne lesions, with the goal of eliminating inflammation recurrence in treated areas. The system has been shown to yield a 45%+ reduction in inflammation after just one treatment. Other key features of the Accure Laser System include:

• Utilizes a unique wavelength that has not previously been clinically available
• Leverages unique pulsing strategy, precise and safe closed-loop laser control and integrated temperature monitoring through an infrared camera
• Is designed for ease of use and relatively short treatment time (30 to 45 minutes)
• Is equipped with single-use treatment tip and accessories

Treatments are customized to each patient, depending on skin types and case severity, and can range from one to six treatment sessions administered three to six weeks apart. Accure Acne believes its technology is the only 1,726 nm laser with CE Mark Clearance for acne treatment on the market. The Accure Laser System was developed in partnership with Quanta System, a Milan, Italy, laser tech developer with over four decades of experience. The company has already launched an early adopter program in the European Union, with the first orders received and delivered in Italy in Q2 2021, through Quanta’s distribution channel. A broader EU commercial launch is scheduled for H2 2021, with plans for an early adopter program in the U.S. to begin in H1 2022 and broader commercial launch in H2 2022. New Pivotal Acne Study The Accure Laser System’s efficiency and safety of treatment across all genders, ages, races and skin types has so far been confirmed through four IRB-approved clinical studies. Research showed a 45% reduction of acne lesions after just one treatment and an 80% reduction after the fourth treatment. Accure Acne is now conducting a new pivotal acne study, restarted in January 2021, based on safety reports from the four IRB-approved clinical trials. This open-label study will enroll 75 patients 16 years and older who will undergo four treatments approximately one month apart. The study is expected to be completed in early 2022, following several checkpoints to monitor for progress and durability – at three months, six months, nine months and 12 months after the fourth and final treatment. This clinical trial will be key to the company’s efforts to secure FDA approval in the United States. Private Placement Offering Accure Acne launched a private placement offering pursuant to Rule 506(c) of Regulation D under the Securities Act. The private placement, launched in April 2021 on the M-Vest platform, aims to raise up to $20 million in Series A Convertible preferred stock. The proceeds will be used to fund the pivotal acne study, ongoing operations and infrastructure needs, while also creating an EU-based sales team and global marketing teams and conducting pre-commercialization operations in the U.S. For more information, visit the company’s offering page on M-Vest. Management Team Christopher Carlton is Co-Founder, Chief Executive Officer and Chairman of the Board of Accure Acne. He has extensive industry experience as well as a demonstrated track record of entrepreneurial success with high-growth public companies and new product launches on the global medical and aesthetic markets. His previous tenures include CEO of Quanta Aesthetic Lasers USA LLC; President, NA for Syneron-Candela, a prominent company in the aesthetic energy-based device market; Vice President and Global General Manager – Interventional Oncology for Covidien Ltd.; CEO for SRI Surgical; and other leadership positions. In 2016, he was recognized as one of the top 10 CEOs and presidents in the industry by Aesthetics Everything(R). Mr. Carlton is a graduate of the GE Management Development Institute-Crotonville and the Program on Negotiation at Harvard Law School, and he holds a BS in Industrial Engineering (With Honors), a Graduate Diploma in Management and an MBA. R. Rox Anderson, MD, is the company’s Co-Founder and Chief Scientific & Medical Officer. One of the most influential scientists in the field of energy-based devices in aesthetics and widely considered the father of the aesthetic industry, Dr. Anderson has contributed significant advancements to acne treatment efforts, including pre-clinical, clinical and product development activities built upon his conceptualization and co-development of microscopic target-selective laser therapy. He has been awarded over 60 national and international patents and has co-authored over 437 scientific books and papers cited by other researchers more than 22,800 times. Dr. Anderson is a Harvard Medical School Professor in dermatology, Director of the Wellman Center for Photomedicine, and adjunct Professor of Health Sciences and Technology at Massachusetts Institute of Technology. Edward Barbera is Co-Founder and Director of Accure Acne. He has more than 35 years of experience developing, running and investing in startups, as well as fundraising, having secured more than $50 million in private equity for a company he founded. Mr. Barbera began his career as a Senior Consultant with Peat, Marwick, Mitchell & Co. and has since held key leadership roles in business development, acquisitions, capital formation and the operation of numerous startups. He has a Bachelor of Business Administration degree with a major in accounting from the University of Massachusetts – Amherst and has previously been a member of the National and Colorado Societies of CPAs. The Accure Acne leadership and medical teams are further comprised of experts and professionals with extensive experience in technology, software, engineering and medical devices, as well as specialists in acne treatment and laser-based treatment options in dermatology and other medical fields. For more information, visit the company’s website at www.AccureAcne.com. NOTE TO INVESTORS: The latest news and updates relating to Accure Acne are available in the company’s newsroom at https://ibn.fm/ACNE

• While all wines are plant-based, not all of them are vegan because traditional winemaking employs animal-based fining agents
• Vegan wines are clarified and stabilized using either bentonite or natural settlement, but vegans struggle to find such wines
• PlantX recently added vegan wines to its expanding product selection on its US e-commerce platform, targeting the growing population of vegans in the US
• The move also appears to be leveraging the trends in both the alcoholic beverage market and the e-commerce sector

While all wines are derived from grapes and sometimes yeast – meaning they are plant-based – not all wines are vegan. This is because some aspects of traditional winemaking, particularly the fining process, employ animal products. A process that stabilizes and clarifies the wine by removing hydrogen sulfide, bitter flavors (or rough tannins, to wine fiends), and microscopic particles that may cause the wine to become cloudy or hazy after bottling, fining typically uses egg whites, as well as fish and milk derivatives. This creates an end product that isn’t vegan – vegans do not consume any form of animal product. In contrast, vegan wines, which still undergo the fining process, do not use animal derivatives. Wineries instead rely on bentonite, a clay, or forego fining agents altogether – given ample time, the impurities settle naturally out of the wine. So, according to a 2018 Washington Post article, the use of animal-based fining agents may not be as widespread as many think (https://ibn.fm/PXiUx). However, because most of the wines available for sale are usually mass-produced and rushed to the market, one cannot be too sure. In fact, vegans have voiced their frustrations at not readily finding vegan wines in shops or restaurants (https://ibn.fm/EONQb). This is where PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a company intent on redefining the plant-based community through e-commerce, comes in. PLTXF recently announced it is now offering vegan wines as part of its expanding product selection on its US e-commerce platform. The addition, announced July 12, will feature a curated selection of high-quality vegan wines from Gravel Bar Winery, Pino Cellars, Veuve Clicquot, and Rare Earth (https://ibn.fm/qWi5u). “The alcoholic beverage market is one of the fastest-growing industry segments in the US and globally,” stated PlantX CEO Julia Frank. “The new vertical will allow PlantX to holistically meet customer demands and expectations by expanding its product offerings in line with its mission and values.” Findings contained in IWSR’s recent Drinks Market Analysis corroborate Julia’s observations. In 2020, the total alcoholic beverage consumption volume increased by +2.0%, the most significant growth since the early aughts. IWSR’s projections show that the consumption volume for 2021 will be up +3.8%. Such positive statistics are also replicated in e-commerce, especially given that the pandemic spawned increased online alcohol sales. “E-commerce alcohol sales in the US are expected to see average annual growth of nearly 45% in value over the next four years,” said IWSR’s COO Brandy Rand (https://ibn.fm/dzcLd). PlantX’s inclusion of vegan wines as part of its online portfolio, therefore, appears to be leveraging the trends in both the alcoholic beverage market and e-commerce sector. Additionally, this latest move embodies the company’s commitment to becoming the one-stop shop for everything plat-based by addressing the needs and wants of its customers, including the growing vegan community in the US, in the most comprehensive and holistic ways. “We consider the PlantX community our own family and obsess over meeting their needs while exceeding customer expectations,” reads the company’s website. The addition of vegan wines on its US platform fulfills this commitment. Just recently, PlantX moved to leverage the pandemic-induced shopping habits in Canada by partnering with two established online marketplaces, in effect meeting the needs of the majority of consumers who have since shifted to e-shopping. PlantX is a high-growth company focusing on consumer-packaged goods (“CPG”) for the plant-based community. Its e-commerce platform offers customers across North America access to more than 10,000 plant-based products. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• China has taken steps to regulate the Bitcoin mining and trading, fueling increased interest in overseas providers of crypto mining services
• ISWH has partnered with Bit5ive to innovate infrastructure needed to run innovative crypto mining projects
• Company has fundamental belief in long-term future viability of cryptocurrency systems as legitimate platforms for global commerce

The world of Bitcoin took a hit earlier this year, falling almost 50% after China increased its efforts to regulate the space (https://ibn.fm/twCpI). Concerns about the cryptocurrencies are nothing new, and ISW Holdings (OTC: ISWH), a global brand management holdings company, has established itself in the cryptocurrency mining space and is committed to providing compliant, efficient and profitable crypto mining projects. “Beijing stepped up its efforts to crack down on Bitcoin mining and trading, sending the digital currency tumbling,” a recent article reported. “Bitcoin took a hammering after the latest Chinese move and is now down nearly 50% from its all-time high. It shed as much as 17% on Sunday, before paring some losses and was last trading steady in Asia.” The article noted that a Chinese State Council committee announced the efforts May 21, the first time the council has targeted virtual currency mining, a big business in China that accounts for as much as 70% of the world’s crypto supply. “Investor protection and prevention of money laundering are particular concerns of governments and financial regulators who are grappling with whether and how they should regulate the cryptocurrency industry,” noted the article, which also observed that Chinese miners were contacting overseas service providers to pave way for exports of mining rigs in the future.” ISW Holdings has partnered with Bit5ive, a global leader in cryptocurrency mining, to innovate the infrastructure needed to run profitable and efficient crypto mining projects. As a result, the company developed a revolutionary Pod5 Cryptocurrency Mining Pod, which has been in full operation at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania since February (https://ibn.fm/osx8u). “We are very excited to finally be ready to launch full mining operations at a time when margins are at historic levels following further strength in the value of cryptocurrency assets,” said ISW Holdings president and chair Alonzo Pierce when announcing the news. “But make no mistake about it: we are doing this because we have a fundamental belief in the long-term future viability of cryptocurrency systems as stores of value and legitimate platforms for global commerce. We started diversifying our cash into Bitcoin nearly two years ago. And we partnered with Bit5ive early last year and began the design for our Pod5 unit when Bitcoin was still under $10,000 per coin.” Designed in partnership with Bit5ive and geared primarily for the cryptocurrency mining industry, the Pod5 Datacenter offers next-generation, dynamic, self-management functionality, plug-and-play operation, virtually nonexistent maintenance needs, and an industry best-in-class 1.06 Power Usage Effectiveness score. The Pod5 is a strong example of ISWH’s commitment to and position in the crypto space. ISW Holdings is a diversified portfolio company comprised of essential business lines that serve consumer product demands. The company’s expertise lies in strategic brand development and early growth facilitation, as well as brand identity through its proprietary procurement process. Together with its partners, ISWH seeks to provide a structure that meets large scalability demands and anticipated marketplace needs. The company meets those needs through a variety of strategic innovative processes. ISW Holdings is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency. For more information, visit the company’s website at www.ISWHoldings.com. NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

• Infobird successfully launches Intelligent Quality Inspection SaaS for a leading fintech company
• Infobird’s Intelligent Quality Inspection system will enhance the fintech company’s management and customer service capabilities
• Infobird researched and analyzed the customer service business scenarios of its client, and built a flexible multi-dimensional quality inspection model

Infobird (NASDAQ: IFBD) Software is a SaaS (Software-as-a-Service) company, providing AI-enabled end-to-end (“B2B”) customer engagement solutions in China, mainly for the finance segment. A premier provider of customer engagement software-as-a-service (“SaaS”) solutions in China, the company announced the successful implementation of its Intelligent Quality Inspection SaaS with one of the leading Fintech companies in China. With the launch of Infobird’s Intelligent Quality Inspection SaaS, Fintech has initiated intelligent management and operations for its client’s customer service platform, paving way for a further upgrade of its customer service (https://ibn.fm/auARB). The Fintech company introduced Infobird’s Intelligent Quality Inspection system to enhance its management and customer service capabilities. The Inforbird client has greatly advanced its customer service quality inspection from manual inspection by random sampling to automatic inspection resulting in a multitude of benefits in the form of a 100% quality inspection coverage rate with improved managerial efficiency. The employment of the SaaS System led to cutting down of services of quality inspectors, resulting in cost curtailment. The quality inspection efficiency also increased by more than 100 times. Inforbird has designed and developed Intelligent Quality Inspection SaaS for the Fintech client company. It researched and analyzed the customer service business scenarios of its client, and built a flexible multi-dimensional quality inspection model. Quality inspection personnel can now concentrate on more critical areas of work, such as conducting customer service training and management work and achieve greater productivity. Some performance-enhancing features of Infobird’s Intelligent Quality Inspection system are:

• Extensive inspection and targeted enhancement of services
• 100% automatic and efficient, enhancing workforce efficiency
• Multi-dimensional reports comprehensively improve management efficiency

In 2020, the SaaS industry in China was valued at $3.3 billion, an increase of 43.5% over 2019. The emergence of the pandemic acted as a catalyst to remote work opportunities has also accelerated the increased acceptance of cloud business services. A provider of customer engagement software-as-a-service (“SaaS”) solutions in China, Infobird is leveraging this growth opportunity to offer automated and smart capabilities to maximize value for its clients. For more information, visit the company’s website at www.Infobird.com/en/index.html. NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

• Avricore Health is an innovator in pharmacy based point-of-care diagnostics
• The company introduced its flagship technology platform in an Ontario Shoppers Drug Mart pharmacy earlier this month as the lead-out to a 12-store rollout throughout the province
• Avricore’s trademarked HealthTab network is making diagnostic tools for diabetes and cardiovascular disease management accessible to patients and the Shoppers Drug Mart agreement provides community locations as well as pharmacist support
• The trial rollout showed successful use by over 90 patients during a week-and-a-half period with seamless pharmacist personnel assistance for more than 600 test results
• Financing programs in January and February helped Avricore retire $1 million in debt with enough left over to help fund the company’s platform expansion

Pharmacy diagnostics solutions developer Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is celebrating the successful test rollout of its flagship platform for assessing cardiovascular disease and diabetes in Shoppers Drug Mart, Canada’s largest pharmacy network. Avricore’s trademarked HealthTab network technology platform using Abbott Afinion 2(TM) analyzers for assessing cardiovascular and diabetes markers will be rolled out for point-of-care service in 12 Shoppers Drug Mart locations under an agreement announced June 3 (https://ibn.fm/I4Lg6). Between July 5 and July 18, Avricore conducted an initial trial period of the health management data platform in an Ontario, Canada Shoppers Drug Mart store and found that more than 90 patients were tested and over 600 results were reported during the week and a half period. “This is really profound because having access to lab-accurate results at our fingertips means we can better help family physicians by conducting regular follow up using advanced diagnostics with our diabetic and cardiovascular patients more effectively,” pharmacist and associate owner Mohamed Adel Elsabakhawi stated (https://ibn.fm/QId4K). The purpose of the rollout is to help patients, beginning in Ontario, to live life well using effective tools and services to successfully manage their overall health with the support of a trusted pharmacist. The world’s leading health organizations and experts have made accessibility to self-help management technology an increasing priority, and walk-in community pharmacies are ideal hub locations for patients to seek those services for diagnosing infections and preventing or treating chronic medical conditions. Last year, the global point-of-care diagnostics market was evaluated at nearly $34.5 billion in revenue, according to Fortune Business Insights, and was expected to grow at a compound annual growth rate (“CAGR”) of 9.4 percent through 2028 to reach $81.37 billion (https://ibn.fm/juCx0). Avricore secured two rounds of financing in early 2021 — one that closed $1.5 million and a second that brought in $1.54 million, with warrants for more than $1 million also exercised — which allowed the company to repay a secured debt of $1 million with sufficient extra cash to advance expansion plans (https://ibn.fm/SfMO3). The 12 Ontario Shoppers Drug Mart pharmacies have now all received their HealthTab systems and are in the process of bringing them online as part of that expanding effort to help patients manage their care. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• HempFusion’s acquisition of Sagely Naturals opens the company to over 14,000 additional retail stores
• It marks a massive milestone following the $17 million TSX IPO in January 2020
• HempFusion looks to more than triple its 2020 revenue as this is part of the company’s expansion plan for 2021 and beyond
• The move builds on HempFusion’s five-channel strategy while playing into Sagely Naturals’ opportunities and strengths

2021 is proving to be a good year for HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO). In January, it completed its $17 million IPO to start trading on the Toronto Stock Exchange (“TSX”) (https://ibn.fm/8hTot). Fast forward to July; the company acquired Sagely Naturals in its most significant move yet as it works on a five-channel expansion strategy to conquer various markets, including the Middle East, China, India, Mexico, Europe, and South Korea (https://ibn.fm/cMnAc). HempFusion’s acquisition of Sagely Naturals opens it to an additional 14,000 stores along with the latter’s retail distribution footprint. It also opens the company to product efficiencies across the topicals line while diversifying its overall product line that features its proprietary formulations. Before Sagely Naturals’ acquisition, HempFusion offered 48 different products under a handful of brands, including Biome Research, HF Labs, Probulin Probiotics, and HempFusion (https://ibn.fm/QSoSq). They were sold in at least 4,000 retail locations in all 50 states within the United States through five main channels: e-commerce, natural health retailers, convenience stores, doctors/practitioners, and big-box/food and drug mass. With Sagely Naturals in the picture, HempFusion now has access to the company’s robust distribution systems and infrastructure. Additionally, it has the opportunity to grow further its product line and, most importantly, leverage Sagely Naturals’ industry-leading marketing, advanced customer/channel relationships, and its proven innovation. Also, with Sagely Naturals’ acquisition, HempFusion looks to more than triple its 2020 revenue with its expansion plan for 2021 and beyond. “We are incredibly excited to complete the acquisition of Sagely Naturals which provides HempFusion with a significant increase in revenue and immediate distribution to up to an additional 14,000 retail points nationally,” noted John Mitchell, the Chief Executive Officer (“CEO”) of HempFusion. “Integration has been underway over the past several weeks, and we look forward to driving shareholder value through continued growth in 2021 and 2022 both domestically and internationally with our expanding family of brands,” he added. So far, HempFusion has successfully managed to win over big retailers with its hemp CBD products. Most notably, the company’s presence on Amazon has played a vital role in its success, brand recognition, and overall brand perception. With the Sagely Naturals’ acquisition, HempFusion plans on taking it a step further while also paying close attention to regulatory compliance procedures that will allow it to expand to other key markets across the world. HempFusion’s focus over the past two and a half years has been on building a solid catalog for its products, ensuring all regulatory compliance guidelines are met and expanding its retail store footprint. With the CBD sector projected to get to $16.8 billion by 2025, the Sagely Naturals’ acquisition could not have come at a better time. HempFusion is a leading health and wellness CBD company that utilizes the power of whole-food hemp nutrition. The company is committed to consistently meeting and exceeding the high standards required by retailers and consumers by prioritizing the quality and consistency of its products. The company is U.S. Hemp Authority Certified and even serves as a board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products. Sagely Naturals’ acquisition marks a key milestone for HempFusion in its 2021 expansion plan. It builds on the company’s progress so far while laying down a solid foundation for its future expansion in terms of its product line and market reach. For more information, visit the company’s website at www.HempFusion.com/corporate-information. NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://ibn.fm/CBDHF

• Ideanomics plans to release its 2021 second-quarter financial results on Monday, August 16, 2021
• The press release is scheduled at 4 pm ET and will be followed by a conference call at 4:30 pm ET
• The call will have the company’s senior management sharing their thoughts on the company’s performance
• It will also have a question-and-answer session for the audience

Ideanomics (NASDAQ: IDEX) will release its 2021 second-quarter financial results on Monday, August 16, 2021. The press release will be issued at 4 pm ET and will be accompanied by a conference call at 4:30 pm ET (https://ibn.fm/uDgF9). The event will feature Ideanomics’ senior management, where they will share their thoughts on its performance so far in the 2021 fiscal year. The session will also provide engagement with the audience, where attendees will get the chance to ask the management questions and have the latter respond to them (https://ibn.fm/x7xbE). Ideanomics is a company that is playing a pivotal role in the adoption of commercial electric vehicles. Its business also involves offering support for next-generation financial services and fintech products. The company is more known known, specifically for its electric vehicle division, Ideanomics Mobility. Ideanomics also has a fintech side to their business under the Ideanomics Capital division. Should you be interested in attending the virtual conference, there are two options to choose from, namely:

1. Webcast Link: https://ibn.fm/30z5X
2. Dial-in Number: 877-407-3107 or 201-493-6796 (Toll-Free for the United States) and Canada

To view the replay of the virtual conference and read the earnings material, check out the company’s investor relations website https://investors.ideanomics.com. For more information, visit the company’s website at www.Ideanomics.com. NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

• President Biden signed executive order directing U.S. Department of Health and Human Services to consider issuing proposed rules to allow hearing aids sales over the counter
• INND positioned to capture market share through online DTC sales of Bluetooth-powered self-adjusting rechargeable hearing aids
• Company recently launched massive six-month campaign to run a minimum of 660 commercials across major networks including Fox News, Bloomberg, Fox Business Network, CNN, CNBC, Newsmax TV, MSNBC

With the aim of promoting “greater competition in the American economy”, President Biden signed a sweeping executive order in early July that directs the U.S. Department of Health and Human Services “to consider issuing proposed rules within 120 days for allowing hearing aids to be sold over the counter” (https://ibn.fm/oG58N). In anticipation of the increased demand for over the counter (“OTC”) hearing aids, InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently launched a six-month national “Media Blitz” campaign aimed at an estimated 48 million Americans currently suffering from hearing loss (https://ibn.fm/kdCpp). Depending on the level of technology, hearing aids can cost up to $6,000 for each device, making them prohibitively expensive for millions of hearing-impaired Americans (https://ibn.fm/71geF). “A major driver of the expense is that consumers must get them from a doctor or a specialist, even though experts agree that medical evaluation is not necessary,” reads the executive order summary (https://ibn.fm/vBRAZ). “Rather, this requirement serves only as red tape and a barrier to more companies selling hearing aids. The four largest hearing aid manufacturers now control 84% of the market”. InnerScope Hearing Technologies is favorably positioned to capture the anticipated increase in consumer demand through direct-to-consumer sales of its Bluetooth-powered self-adjusting rechargeable hearing aids at its dedicated online store. The Company recently launched a “Media Blitz” campaign in partnership with New to The Street TV to increase public awareness about hearing loss and drive sales to its website. The six-month campaign guarantees a minimum of 660 commercials over the period, including 156 digital billboards running three times per hour throughout lower Manhattan in New York City. Along with broadcasting televised commercials on Fox News, Bloomberg, Fox Business Network, CNN, CNBC, Newsmax TV, and MSNBC, the company plans to use the content – owned by InnerScope Hearing Technologies as part of the agreement – on its website and social media platforms. “The launch of our Hearing Loss Media Blitz Campaign could not have come at a better time, especially after last week’s executive order from President Biden and his remarks on making hearing aids more affordable and able to be sold over the counter in pharmacies without any medical evaluation,” said InnerScope Hearing Technology CEO Matthew Moore. “InnerScope’s hearing aids work with any smartphone, require no medical evaluation or professional help, and deliver the same personalized hearing quality and satisfaction as hearing aids sold by hearing care professionals.” InnerScope Hearing Technologies is dedicated to improving the quality of life for over 70 million North Americans and 1.5 billion people worldwide that suffer from hearing impairment and hearing-related issues. The company produces, distributes and markets direct-to-consumer FDA-registered Bluetooth app-controlled hearing aids, Bluetooth app-controlled personal sound amplifier products and hearing-related treatment therapies that include doctor-formulated dietary hearing and tinnitus supplements and other health-related products. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

Microdose Psychedelic Insights (“Microdose”) are set to host their virtual Pyschedelic Capital: July 2021 conference on July 29, 2021. The event is set to play host to a number of companies, drawn from across the psychedelics industry, including, but not limited to, the functional mushrooms and phytopharmaceutical sectors. Microdose Psychedelic Insights, a cutting-edge media company focused around promoting content, financial analysis, and engaging events focused around the psychedelics industry, have gained renown for their unique vision towards shifting the global perception around psychedelic medicine through a series of innovative events. Part of an investor conference series diving deep into psychedelic medicine investment, Microdose’s Psychedelic Capital conference seeks to introduce investors and attendees to a curated group of CEOs, capital advisors and investment luminaries from around the world. This year’s July conference will be inaugurated by an introductory talk, delivered by Patrick Moher, CEO of Microdose Psychedelic Insights; and Richard Skaife, Founding Partner at The Conscious Fund, an early-stage venture capital investor within the plant powered medicine sector. The conference will subsequently play host to a number of corporate presentations from companies focused around medicinal mushroom-based products, the cultivation and processing of pharmaceutical and medicinal cannabis, psychedelic-based disease modifying therapies, among various others. In addition, the event will also feature an exciting roundtable symposium focused around the latest ongoing developments and breakthroughs within the global psychedelics industry. Additional information about the Psychedelic Capital: July 2021 conference, as well as details for registration, can be found on the Psychedelic Capital conference website at https://microdose.buzz/shop/events/psychedelic-capital/psychedelic-capital-jul-2021/ About Microdose Psychedelic Insights: Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine. About Psychedelic Capital: This online event programming is dedicated to providing investment grade information for the nascent psychedelic sector and presents a curated group of CEOs, financial experts, thought leaders and investment luminaries from around the globe. Presentations are 30 minutes in length, with 10 minutes always allocated to a one-on-one Q&A session with the audience. Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space. Contact: Microdose Psychedelic Insights kristina@microdose.buzz Media Contact:  InvestorBrandNetwork (IBN) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com